Clinical Trials Insight: 700028166
Phase of Trial: Phase III
Latest Information Update: 28 Nov 2007
At a glance
- Drugs Doxorubicin (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Sponsors Supratek Pharma
- 28 Nov 2007 Special Protocol Assessment agreement reached with the US FDA.
- 06 Nov 2007 New trial record.